Literature DB >> 33567520

The Key Role of Nucleic Acid Vaccines for One Health.

Anders Fomsgaard1, Margaret A Liu2.   

Abstract

The ongoing SARS-CoV-2 pandemic has highlighted both the importance of One Health, i.e., the interactions and transmission of pathogens between animals and humans, and the potential power of gene-based vaccines, specifically nucleic acid vaccines. This review will highlight key aspects of the development of plasmid DNA Nucleic Acid (NA) vaccines, which have been licensed for several veterinary uses, and tested for a number of human diseases, and will explain how an understanding of their immunological and real-world attributes are important for their efficacy, and how they helped pave the way for mRNA vaccines. The review highlights how combining efforts for vaccine development for both animals and humans is crucial for advancing new technologies and for combatting emerging diseases.

Entities:  

Keywords:  Cytolytic T Lymphocyte (CTL); DNA vaccines; immune responses; mRNA vaccines; one health; plasmid

Year:  2021        PMID: 33567520      PMCID: PMC7916035          DOI: 10.3390/v13020258

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  101 in total

1.  Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.

Authors:  Katalin Karikó; Michael Buckstein; Houping Ni; Drew Weissman
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

2.  Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV.

Authors:  V Niborski; Y Li; F Brennan; M Lane; A M Torché; M Remond; M Bonneau; S Riffault; C Stirling; G Hutchings; H Takamatsu; P Barnett; B Charley; I Schwartz-Cornil
Journal:  Vaccine       Date:  2006-07-07       Impact factor: 3.641

3.  Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.

Authors:  Ingrid Karlsson; Marie Borggren; Jens Nielsen; Dennis Christensen; Jim Williams; Anders Fomsgaard
Journal:  Hum Vaccin Immunother       Date:  2017-06-14       Impact factor: 3.452

4.  Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

Authors:  T M Fu; J B Ulmer; M J Caulfield; R R Deck; A Friedman; S Wang; X Liu; J J Donnelly; M A Liu
Journal:  Mol Med       Date:  1997-06       Impact factor: 6.354

5.  A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.

Authors:  P K Gupta; S Sharma; S S Walunj; A A Patil; A Rai; M Saini
Journal:  Acta Virol       Date:  2006       Impact factor: 1.162

6.  Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans.

Authors:  Marie Borggren; Jens Nielsen; Karoline Bragstad; Ingrid Karlsson; Jesper S Krog; James A Williams; Anders Fomsgaard
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 7.  Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform.

Authors:  Peter Gottlieb; Paul J Utz; William Robinson; Lawrence Steinman
Journal:  Clin Immunol       Date:  2013-09-01       Impact factor: 3.969

8.  DNA vaccination of the American crow (Corvus brachyrhynchos) provides partial protection against lethal challenge with West Nile virus.

Authors:  Michel L Bunning; Patricia E Fox; Richard A Bowen; Nicholas Komar; Gwong-Jen J Chang; Tully J Speaker; Michael R Stephens; Nicole Nemeth; Nicholas A Panella; Stanley A Langevin; Paul Gordy; Max Teehee; Patricia R Bright; Michael J Turell
Journal:  Avian Dis       Date:  2007-06       Impact factor: 1.577

Review 9.  A Comparison of Plasmid DNA and mRNA as Vaccine Technologies.

Authors:  Margaret A Liu
Journal:  Vaccines (Basel)       Date:  2019-04-24

10.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

View more
  3 in total

Review 1.  Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects.

Authors:  Zhan Zhang; Qi Shen; Haocai Chang
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

Review 2.  Thermostable Vaccines in Veterinary Medicine: State of the Art and Opportunities to Be Seized.

Authors:  Angela Fanelli; Luca Mantegazza; Saskia Hendrickx; Ilaria Capua
Journal:  Vaccines (Basel)       Date:  2022-02-05

3.  Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2.

Authors:  Ria Lassaunière; Charlotta Polacek; Gregers J Gram; Anders Frische; Jeanette Linnea Tingstedt; Maren Krüger; Brigitte G Dorner; Anthony Cook; Renita Brown; Tatyana Orekov; Tammy Putmon-Taylor; Tracey-Ann Campbell; Jack Greenhouse; Laurent Pessaint; Hanne Andersen; Mark G Lewis; Anders Fomsgaard
Journal:  NPJ Vaccines       Date:  2021-12-20       Impact factor: 7.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.